10.82  -0.06 (-0.55%)		09-30 16:00
Open: 10.72 High: 11.0928 Volume: 49,196		Pre. Close: 10.88 Low: 10.65 Market Cap: 98(M)

Short term
Mid term
Targets	6-month :	14.83	1-year :	17.32
Resists	First :	12.69	Second :	14.83
Pivot price	10.88
Supports	First :	10.22	Second :	8.69
MAs	MA(5) :	11.03	MA(20) :	10.46
	MA(100) :	8.5	MA(250) :	6.89
MACD	MACD :	0.5	Signal :	0.6
%K %D	K(14,3) :	55.2	D(3) :	58.2
RSI	RSI(14): 55.9
52-week	High :	12.69	Low :	4.4

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ ECOR ] has closed above bottom band by 48.2%. Bollinger Bands are 5.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	11.17 - 11.27	11.27 - 11.34
Low:	10.42 - 10.56	10.56 - 10.65
Close:	10.66 - 10.89	10.89 - 11.02

electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches. Its flagship offering, the gammaCore Sapphire, is a portable, rechargeable, and refillable device intended for either regular or intermittent use over many years. Established in 2005, its corporate headquarters are situated in Rockaway, New Jersey.

Sat, 26 Sep 2026
electroCore Has A Line Of Sight At Cash Breakeven (NASDAQ:ECOR) - Seeking Alpha

Fri, 25 Sep 2026
Electrocore Stock Price Forecast. Should You Buy ECOR? - StockInvest.us

Tue, 22 Sep 2026
electroCore (ECOR) director lifts stake to about 364K shares - Stock Titan

Fri, 18 Sep 2026
Full Transcript: electroCore Q2 2026 Earnings Call - Benzinga

Fri, 18 Sep 2026
electroCore (ECOR) Stock Jumps 6.9%: Will It Continue to Soar? - Yahoo Finance

Mon, 14 Sep 2026
Stock grant lifts electroCore (ECOR) co-CEO Michael Fox to 130,000 shares - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	9 (M)
Shares Float	6 (M)
Held by Insiders	32.4 (%)
Held by Institutions	11.6 (%)
Shares Short	322 (K)
Shares Short P.Month	368 (K)

EPS	-1.65
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	-0.32
Profit Margin	-40 %
Operating Margin	-29.4 %
Return on Assets (ttm)	-55 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	28 %
Gross Profit (p.s.)	3.56
Sales Per Share	4.09
EBITDA (p.s.)	-1.52
Qtrly Earnings Growth	0 %
Operating Cash Flow	-10 (M)
Levered Free Cash Flow	-5 (M)

PE Ratio	-6.56
PEG Ratio	0
Price to Book value	-34.91
Price to Sales	2.63
Price to Cash Flow	-10.04

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.